Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: A preclinical study of cervical carcinoma and melanoma xenografts

Acta Oncologica

Volumn 52, Issue 3, 2013, Pages 604-611

  Ovrebo, Kirsti Marie ^a   Ellingsen, Christine ^a   Hompland, Tord ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM; PENTETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE MARKER; FEMALE; LYMPH NODE METASTASIS; MELANOMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROBABILITY; STUDENT T TEST; TUMOR XENOGRAFT; UTERINE CERVIX CARCINOMA; ADULT; CANCER TRANSPLANTATION; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; INGUINAL LYMPH NODE; LYMPHADENOPATHY; METASTASIS POTENTIAL; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIMARY TUMOR; TUMOR VOLUME; VOLUME OF DISTRIBUTION; WHOLE BODY IMAGING;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SKIN NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 84875205024     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.689851     Document Type: Article

References (33)

1. Jennings D, Raghunand N, Gillies RJ. Imaging hemodynamics. Cancer Metastasis Rev 2008;27:589-613
2. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32 (Pubitemid 29463104)
3. Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol 2007;8:63-74 (Pubitemid 44943092)
4. Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 2006;24: 3293-8 (Pubitemid 46622069)
5. Benjaminsen IC, Graff BA, Brurberg KG, Rofstad EK. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: A preclinical study of human melanoma xenografts. Magn Reson Med 2004;52: 269-76 (Pubitemid 39025270)
6. Egeland TAM, Simonsen TG, Gaustad JV, Gulliksrud K, Ellingsen C, Rofstad EK. Dynamic contrast-enhanced magnetic resonance imaging of tumors: Preclinical validation of parametric images. Radiat Res 2009;172:339-47
7. Egeland TAM, Gaustad JV, Vestvik IK, Benjaminsen IC, Mathiesen B, Rofstad EK. Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI. Magn Reson Med 2006;55:874-82
8. Gulliksrud K, Ø v rebø KM, Mathiesen B, Rofstad EK. Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol 2011;98:360-4
9. Egeland TAM, Gulliksrud K, Gaustad JV, Mathiesen B, Rofstad EK. Dynamic contrast-enhanced MRI of tumor hypoxia. Magn Reson Med 2012;67:519-30
10. Vaupel P, Mayer A. Hypoxia in cancer: Signifi cance and impact on clinical outcome. Cancer Metastasis Rev 2007; 26:225-39 (Pubitemid 47101660)
11. Ellingsen C, Natvig I, Gaustad JV, Gulliksrud K, Egeland TAM, Rofstad EK. Human cervical carcinoma xenograft models for studies of the physiological microenvironment of tumors. J Cancer Res Clin Oncol 2009;135:1177-84
12. Rofstad EK, Mathiesen B. Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia. Neoplasia 2010;12:889-98
13. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567-71 (Pubitemid 24129954)
14. Ellingsen C, Egeland TAM, Galappathi K, Rofstad EK. Dynamic contrast-enhanced magnetic resonance imaging of human cervical carcinoma xenografts: Pharmacokinetic analysis and correlation to tumor histomorphology. Radiother Oncol 2010;97:217-24
15. Killion JJ, Radinsky R, Fidler IJ. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 1999;17:279-84 (Pubitemid 29210167)
16. Talmadge JE, Singh RK, Fidler IJ, Raz A. Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 2007;170:793-804 (Pubitemid 47339349)
17. Gaustad JV, Benjaminsen IC, Graff BA, Brurberg KG, Ruud EBM, Rofstad EK. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2005;21:792-800 (Pubitemid 40770872)
18. Egeland TAM, Gaustad JV, Galappathi K, Rofstad EK. Magnetic resonance imaging of tumor necrosis. Acta Oncol 2011;50:427-34
19. Øv rebø KM, Hompland T, Mathiesen B, Rofstad EK. Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol 2012;102: 429-35
20. Ellingsen C, Egeland TAM, Gulliksrud K, Gaustad JV, Mathiesen B, Rofstad EK. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2009;73:838-45
21. Sundf ør K, Lyng H, Rofstad EK. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer 1998; 78:822-7 (Pubitemid 28418321)
22. Pitson G, Fyles A, Milosevic M, Wylie J, Pintilie M, Hill RP. Tumor size and oxygenation are independent predictors of nodal disease in patients with cervix cancer. Int J Radiat Oncol Biol Phys 2001;51:699-703
23. Cairns RA, Hill RP. Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res 2004;64: 2054-61 (Pubitemid 38339453)
24. Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K, Graff BA. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res 2002;62:1847-53 (Pubitemid 34408512)
25. Ellingsen C, Hompland T, Mathiesen B, Rofstad EK. Microenvironment- associated lymph node metastasis of human cervical carcinoma xenografts. Acta Oncol 2012;51: 465-72
26. Schoppmann SF, Fenzl A, Schindl M, Bachleitner- Hofmann T, Nagy K, Gnant M, et al. Hypoxia inducible factor-1 〈 correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat 2006; 99:135-41 (Pubitemid 44268261)
27. Min Y, Ghose S, Boelte K, Li J, Yang L, Lin PC. C/EBP-™ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1 〈 . Oncogene 2011;30:4901-9
28. Chaudary N, Milosevic M, Hill RP. Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer. Gynecol Oncol 2011;123:393-400
29. Li LZ, Zhou R, Xu HN, Moon L, Zhong T, Kim EJ, et al. Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential. Proc Natl Acad Sci USA 2009;106:6608-13
30. Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, et al. Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 2006;82:699-757 (Pubitemid 44832019)
31. Pacheco-Torres J, L óp ez-Larrubia P, Ballesteros P, Cerd á n S. Imaging tumor hypoxia by magnetic resonance methods. NMR Biomed 2011;24:1-16
32. Øv rebø KM, Gulliksrud K, Mathiesen B, Rofstad EK. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2011;81:255-61
33. Øv rebø KM, Ellingsen C, Galappathi K, Rofstad EK. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts. Int J Radiat Oncol Biol Phys 2012;83:e121-7